BOT 1.35% 37.5¢ botanix pharmaceuticals ltd

Bot Chart, page-12673

  1. 2,543 Posts.
    lightbulb Created with Sketch. 565
    There is no logic in CR now..we are 2 weeks away from FDA and first sales..

    CR upon FDA approval - makes no sense either..let first 3-6 months dictate your destiny and raise then if you want to expand faster but with solid margins and a line of credit ( which business can easly obtain because of FDA) - I see no prudent why they would do it..


    Remember 20-30 sales people- this is only increase ra cost we will have and that is usd 5mln...hired to Sell!!!


    COGS - should ..be low under usd 50per bottle max.
    Product will sell at 750 less 15-20% given to middle man ( dermatologist, telesales, distributors, promotoers)..business will inly produce if it can sell..

    Marketing cost - max 3mln in first year..( digital spend (on TickTok, FB, etc)


    if we make in first year say usd 100mln( we need to find 30 000 customers @ 6 prescribtions per year) in Net Sales..I expect at least 40% of it will be net profit or cash..

    so, the cash we have is enough for a good 12-18months run..
    Last edited by Lev20: 04/06/24
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
0.005(1.35%)
Mkt cap ! $678.7M
Open High Low Value Volume
37.5¢ 38.5¢ 37.5¢ $1.701M 4.493M

Buyers (Bids)

No. Vol. Price($)
9 523247 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 146093 2
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.